News

Weight loss medications like Wegovy can be life-changing for people living with obesity or excess weight with related health ...
The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...
A doctor has issued a warning to people who use weight loss jabs over the 'golden dose'. The use of GLP-1 medication, such as ...
Kimberly Bongiorno, 55, turned to plastic surgery to help with changes to the appearance of her face and neck after using Ozempic for weight loss.
Eli Lilly’s trial evaluating Mounjaro in reducing cardiovascular risk met its endpoint, though missed analyst expectations.
The Trump administration outlines a plan to cover weight-loss drugs under Medicare and Medicaid, allowing certain state ...
At their peak last year, one share in the company Novo Nordisk cost $142; now, they can be bought for under $50.
Eli Lilly and Novo Nordisk are actively exploring other medical uses for their GLP-1 drugs, and have already seen some success ...
The introduction of GLP-1s for weight loss has been a dysfunctional mess, thanks to pharmaceutical companies, insurance plans ...
Rechelle never thought her body would let her down. She was 35, living in London with a dream job. She was even making plans ...
Novo Nordisk has struggled to adapt to very high demand and a market where celebrities are more influential than doctors.
Some of the most recognizable brand names that could be impacted by new tariffs include Ozempic and Wegovy, two injectable ...